The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Early-onset sepsis remains a common and serious problem for neonates, especially preterm
infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia …

Abstract Background Invasive fungal diseases (IFDs) remain important causes of morbidity
and mortality. The consensus definitions of the Infectious Diseases Group of the European …

Background The emergence of antifungal resistance threatens effective treatment of
invasive fungal infection (IFI). Invasive candidiasis is the most common health care …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

The number of immunosuppressive patients has increased significantly in recent years.
These patients are at risk for opportunistic infections, especially fungal infections …

Invasive infection due to Candida species is a condition associated with medical progress. It
is a common health care–associated infection and is widely recognized as a major cause of …

Considerable progress has been made in the prevention, diagnosis, and management of
pediatric patients with invasive fungal disease (IFD). The reported decreasing trend in the …

Neonatal sepsis, a clinical disorder developed by bacterial blood stream infections (BSI) in
neonates, is one of the serious global public health problems that must be addressed. More …

We systematically reviewed and analyzed the available data for galactomannan (GM), β-D-
glucan (BG), and polymerase chain reaction (PCR)–based assays to detect invasive fungal …